Avanos Medical, Inc.
$24.64
▼
-0.99%
2026-04-21 05:30:00
avanos.com
NYQ: AVNS
Explore Avanos Medical, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.15 B
Current Price
$24.64
52W High / Low
$24.72 / $9.3
Stock P/E
—
Book Value
$16.75
Dividend Yield
—
ROCE
1.7%
ROE
-9.07%
Face Value
—
EPS
$-1.57
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
2,287
Beta
1.05
Debt / Equity
16.59
Current Ratio
2.15
Quick Ratio
1.26
Forward P/E
11.34
Price / Sales
0.94
Enterprise Value
$698.72 M
EV / EBITDA
12.84
EV / Revenue
1
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Integer Holdings Corporation | $89.32 | 29.89 | $3.07 B | — | 7.52% | 6.11% | $127.56 / $62 | $50.85 |
| 2. | Bluejay Diagnostics, Inc. | $1.97 | — | $1.94 M | — | -115.88% | -1.17% | $16.68 / $1.65 | $9.88 |
| 3. | Cerus Corporation | $2.05 | — | $397.8 M | — | -7.17% | -25.66% | $2.96 / $1.15 | $0.33 |
| 4. | Adagio Medical Holdings, Inc. | $1.53 | — | $34.43 M | — | -62.51% | -1.55% | $2.87 / $0.74 | $0.56 |
| 5. | Alphatec Holdings, Inc. | $11.55 | — | $1.68 B | — | -10.13% | -6.31% | $23.29 / $9.89 | $0.08 |
| 6. | MaxCyte, Inc. | $0.86 | — | $91.86 M | — | -24.06% | -23.63% | $2.96 / $0.64 | $1.61 |
| 7. | Beta Bionics, Inc. | $12.91 | — | $576.08 M | — | -24.07% | -40.26% | $32.71 / $8.8 | $6.48 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 180.9 M | 177.8 M | 175 M | 167.5 M | 179.6 M |
| Operating Profit | 2.5 M | 0.1 M | 2.5 M | 10.3 M | 18.2 M |
| Net Profit | -1.3 M | -1.4 M | -76.8 M | 6.6 M | -397.3 M |
| EPS in Rs | -0.03 | -0.03 | -1.65 | 0.14 | -8.54 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 701.2 M | 687.8 M | 673.3 M | 684.1 M |
| Operating Profit | 15.4 M | 40.5 M | 4.2 M | 35.5 M |
| Net Profit | -72.9 M | -392.1 M | -61.8 M | 50.5 M |
| EPS in Rs | -1.57 | -8.43 | -1.33 | 1.09 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 1.07 B | 1.15 B | 1.69 B | 1.79 B |
| Total Liabilities | 295.5 M | 325.7 M | 456.1 M | 495.7 M |
| Equity | 778.2 M | 828.5 M | 1.24 B | 1.29 B |
| Current Assets | 355.4 M | 393.4 M | 487 M | 624.1 M |
| Current Liabilities | 165.2 M | 165.9 M | 234.6 M | 191 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 74.7 M | 100.7 M | 32.4 M | 90.9 M |
| Investing CF | -60.6 M | -27.5 M | 21.6 M | -135.4 M |
| Financing CF | -37 M | -49.1 M | -94.2 M | 56.7 M |
| Free CF | 43.1 M | 82.9 M | 14.6 M | 71.6 M |
| Capex | -31.6 M | -17.8 M | -17.8 M | -19.3 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 1.95% | 2.15% | -1.58% | — |
| Earnings Growth % | 81.41% | -534.47% | -222.38% | — |
| Profit Margin % | -10.4% | -57.01% | -9.18% | 7.38% |
| Operating Margin % | 2.2% | 5.89% | 0.62% | 5.19% |
| Gross Margin % | 50.47% | 55.44% | 56.39% | 57.62% |
| EBITDA Margin % | -2.78% | -50.25% | 7.9% | 12.34% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.